Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What affects Integra ITRG stock price 112 20260420 Ispire Technology ISPR Stock Paper Trade Trend Weakens 20260420 Is ZoomInfo Technologies GTM stock relatively secure Drifts Lower 20260420 BMNR BitMine posts 841 percent Q1 2026 revenue growth yet shares fall 183 percent today Is it too late to buy Expedia Group EXPE stock today Q4 2025 Better Than Expected How to hedge Alexandria RE ARE position Trend Weakens 20260501 What Driven Brands DRVN is doing that creates lasting advantage Q3 2025 Earnings Beat Estimates Galaxy Digital GLXY Sector Leadership Galaxy Digital Posts 113 EPS Miss Wider Than Estimated Loss What PrecisionBio DTIL management is focused on executing Q4 2025 Better Than Expected BriaCell BCTXL Climbs 381 Resistance at 114 in Focus 20260514 Liberty FWONA Stock Slides 144 Support at 7797 20260517 US Economy Shows Resilience with 2 GDP Growth in First Quarter ITT ITT Reports Strong Q1 2026 Revenue NA EPS Beats Indias Nykaa Seeks to Bring Meta Into Music Copyright Dispute with Zee Entertainment Vistra Corp VST Rallies 35 as Energy Sector Momentum Builds BlackSky BKSY Stock Analysis Climbs 091 Eyes on 4786 20260520 Banco Bradesco BBD Holds Near Support After Marginal Decline PHIO Q1 2026 Earnings EPS Misses Estimates as ResearchFocused Biotech Maintains Development Pace Unisys Corporation UIS Q1 2026 Earnings EPS Beat Surprises as Cost Controls Drive Profitability NextCure Inc NXTC Q1 2026 Earnings EPS Beat Amid No Revenue and Steep Stock Decline CCEP Q4 2018 Earnings Small EPS Miss amid Operational Challenges BankUnited BKU Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Potential Underlying Strength Immunic IMUX Surges 6 as Biotech Shares Rebound Key Levels to Watch Zentalis Pharmaceuticals ZNTL Rallies 2 as Stock Holds Above Key Support Tungray Technologies TRSG Holds Steady Near Support Amid Low Volatility KALA Bio Dips 65 Support Test Looms as Biotech Faces Pressure